Literature DB >> 33108012

SFLT-1 levels in COVID-19 patients: Association with outcome and thrombosis.

Aurelio Negro1, Angelo Fama2, Domenico Penna2,3, Lucia Belloni4, Alessandro Zerbini4, Pasquale Gianluca Giuri1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33108012     DOI： 10.1002/ajh.26037

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Letter to the Editor: SFlt-1 and PlGF Levels in Pregnancies Complicated by SARS-CoV-2 Infection.

Authors:  Valentina Giardini; Sara Ornaghi; Eleonora Acampora; Maria Viola Vasarri; Francesca Arienti; Carlo Gambacorti-Passerini; Marco Casati; Andrea Carrer; Patrizia Vergani
Journal:  Viruses       Date:  2021-11-27       Impact factor: 5.048

2.  Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcome in pregnant women with COVID-19.

Authors:  J Torres-Torres; S Espino-Y-Sosa; L C Poon; J M Solis-Paredes; G Estrada-Gutierrez; A Espejel-Nuñez; A Juarez-Reyes; A Etchegaray-Solana; Y Alfonso-Guillen; L Aguilar-Andrade; J A Hernández-Pacheco; J R Villafan-Bernal; R J Martinez-Portilla
Journal:  Ultrasound Obstet Gynecol       Date:  2021-12-29       Impact factor: 8.678

Review 3.  COVID-19, Pre-Eclampsia, and Complement System.

Authors:  Chiara Agostinis; Alessandro Mangogna; Andrea Balduit; Azin Aghamajidi; Giuseppe Ricci; Uday Kishore; Roberta Bulla
Journal:  Front Immunol       Date:  2021-11-17       Impact factor: 7.561

4.  Vascular Endothelial Growth Factor Receptor, fms-Like Tyrosine Kinase-1 (Flt-1), as a Novel Binding Partner for SARS-CoV-2 Spike Receptor-Binding Domain.

Authors:  Adel Zaid I Mutahar; Manjunath Devaramani; Renu Dayal; Dinesh Kumar Saini; Paramahans V Salimath; Bharathi P Salimath
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

5.  Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19.

Authors:  Salvador Espino-Y-Sosa; Raigam Jafet Martinez-Portilla; Johnatan Torres-Torres; Juan Mario Solis-Paredes; Guadalupe Estrada-Gutierrez; Jose Antonio Hernandez-Pacheco; Aurora Espejel-Nuñez; Paloma Mateu-Rogell; Angeles Juarez-Reyes; Francisco Eduardo Lopez-Ceh; Jose Rafael Villafan-Bernal; Lourdes Rojas-Zepeda; Iris Paola Guzman-Guzman; Liona C Poon
Journal:  Viruses       Date:  2021-09-23       Impact factor: 5.048

Review 6.  COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.

Authors:  David M Smadja; Steven J Mentzer; Michaela Fontenay; Mike A Laffan; Maximilian Ackermann; Julie Helms; Danny Jonigk; Richard Chocron; Gerald B Pier; Nicolas Gendron; Stephanie Pons; Jean-Luc Diehl; Coert Margadant; Coralie Guerin; Elisabeth J M Huijbers; Aurélien Philippe; Nicolas Chapuis; Patrycja Nowak-Sliwinska; Christian Karagiannidis; Olivier Sanchez; Philipp Kümpers; David Skurnik; Anna M Randi; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2021-06-28       Impact factor: 9.596
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.